Corporate advisors expect Triton to launch a sale of UK-headquartered specialty pharma asset Pharmanovia next year, according to three sources familiar with the situation.
Triton’s Pharmanovia tipped as 2023 sale candidate
Most Popular
Corporate advisors expect Triton to launch a sale of UK-headquartered specialty pharma asset Pharmanovia next year, according to three sources familiar with the situation.